Skip to main content

Table 1 Clinical characteristics for Total biomarker study group (n = 2603) and Nicotine exposure study group (n = 2278)

From: The effect of nicotine-containing products and fetal sex on placenta-associated circulating midpregnancy biomarkers

Maternal and pregnancy characteristics

Total biomarker study group (n = 2603)

Nicotine exposure study group (n = 2278)

N

%

N

%

Fetal sex

    

Male

1371

53.0

1201

53.0

Female

1214

47.0

1066

47.0

Gestational age at blood sampling (weeks)*, mean ± SD

19.8 ± 6.2

 

19.8 ± 6.1

 

16–17

199

7.7

168

7.5

18

811

31.5

695

30.8

19–20

993

38.6

859

38.1

21–23

573

22.2

532

23.6

Maternal age at enrollment (years), mean ± SD

32.3 ± 4.2

 

32.4 ± 4.2

 

 < 30

900

34.5

770

33.8

30–35

1120

43.0

993

43.6

 > 35–40

500

19.2

441

19.4

 > 40

83

3.2

74

3.2

Maternal prepregnancy body mass index (kg/m2), mean ± SD

24.8 ± 3.7

 

24.8 ± 3.7

 

Underweight < 18.5

87

3.4

76

3.4

Normal weight 18.5–24.9

1902

74.9

1669

75.1

Overweight 25.0–29.9

405

16.0

361

16.3

Obese ≥ 30.0

145

5.7

115

5.2

Parity (previous deliveries)

    

0

1694

65.1

1369

60.1

1

717

27.5

717

31.5

 > 1

192

7.4

192

8.4

Country of origin

    

Norway or Sweden

2020

77.6

2020

88.7

Rest of the world

258

9.9

258

11.3

Education (years)

    

Preliminary school only (9–10 years)

18

0.7

18

0.8

High school only

230

8.8

230

10.1

Higher education < 4 years

730

28.0

730

32.2

Higher education ≥ 4 years

1289

49.5

1289

56.8

Other

2

0.1

2

0.1

Snus

    

Never

1762

67.7

1762

77.3

Stopped before pregnancy

343

13.2

343

15.1

Stopped when recognizing pregnancy

160

6.2

160

7.0

Current

13

0.5

13

0.6

Smoking

    

Never

1762

67.7

1762

77.3

Stopped before pregnancy

404

15.5

404

17.6

Stopped when recognizing pregnancy

97

3.7

97

4.3

Current

15

0.6

15

0.7

  1. N, number; SD, Standard Deviation; %, percentage